Nitric oxide production and hepatic dysfunction in patients with postoperative sepsis

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 3, 2000, Pages 197-201

  Satoi, Sohei ^a   Kamiyama, Yasuo ^a   Kitade, Hiroaki ^a   Kwon, A Hon ^a   Takahashi, Kanji ^a   Wei, Tu ^a   Inoue, Tomohisa ^a   Takahashi, Hakuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokine; End product of nitric oxide radical; Hepatic failure; Ketone body ratio; Metabolic disorder; Mitochondrial dysfunction; NAD+ NADH ratio; Systemic inflammatory response syndrome

Indexed keywords

KETONE BODY; NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ELECTRON TRANSPORT; FEMALE; HUMAN; LIVER CELL; LIVER DYSFUNCTION; MALE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; POSTOPERATIVE COMPLICATION; SEPSIS;

AGED; FEMALE; HUMANS; KETONE BODIES; LIVER DISEASES; MALE; MITOCHONDRIA, LIVER; MULTIPLE ORGAN FAILURE; NAD; NITRATES; NITRIC OXIDE; NITRITES; POSTOPERATIVE COMPLICATIONS; SEPSIS;

EID: 0034018718     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03228.x     Document Type: Article

References (35)

1. 1. Sriskandan S, Moyes D, Buttery LK et al. The role of nitric oxide in experimental murine sepsis due to pyrogenic exotoxin A-producing Streptococcus pyogenes. Infect. Immun. 1997; 65: 1767-72.
2. 2. Avila MA, Mingorance J, Martinez-Chantar ML et al. Regulation of rat liver s-adenosylmethionine synthetase during septic shock: Role of nitric oxide. Hepatology 1997; 25: 391-6.
3. 3. Losser MR, Payen D. Mechanisms of liver damage. Semin. Liver Dis. 1996; 16: 357-67.
4. 4. Pastor CM, Losser MR, Payen D. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 1995; 22: 1547-53.
5. 5. Thiemermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol. 1995; 116: 2845-51.
6. 6. Ozawa K, Chance B, Tanaka A et al. Linear correlation between acetoacetate/beta-hydroxybutyrate in arterial blood and oxidized flavoprotein/reduced pyridine nucleotide in freeze-trapped human liver tissue. Biochim. Biophys. Acta 1992; 1138: 350-2.
7. 7. Nakatani T, Spolter L, Kobayashi K. Arterial ketone body ratio as a parameter of hepatic mitochondrial redox state during and after hemorrhagic shock. World J. Surg. 1995; 19: 592-6.
8. 8. Ozawa K, Aoyama H, Yasuda K et al. Metabolic abnormalities associated with postoperative organ failure. A redox theory. Arch. Surg. 1983; 118; 1245-51.
9. 9. Ukikusa M, Ozawa K, Shimahara Y et al. Changes in blood ketone body ratio: Their significance after major hepatic resection. Arch. Surg. 1981; 116: 781-5.
10. 10. Takahashi M, Ueda K, Tabata R et al. Arterial ketone body ratio as a prognostic indicator in acute heart failure. J. Lab. Clin. Med. 1997; 129: 72-80.
11. 11. Nishikawa M, Satoh EF, Kuroki T, Inoue M. Role of glutathione and nitric oxide in the energy metabolism of rat liver mitochondria. FEBS Lett. 1997; 415: 341-5.
12. 12. Kurose I, Miura S, Higuchi H et al. Increased nitric oxide synthase activity as a cause of mitochondrial dysfunction in rat hepatocytes: Roles for tumor necrosis factor α. Hepatology 1996; 24: 1185-92.
13. 13. Kantrow SP, Taylor DE, Carraway MS, Piantadosi CA. Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch. Biochem. Biophys. 1997; 345: 278-88.
14. 14. Stadler J, Billiar TR, Curran RD et al. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 1991; 260: C910-16.
15. 15. Kitade H, Sakitani K, Inoue K et al. Interleukin-1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 1996; 23: 797-802.
16. 16. Kitade H, Kanemaki T, Sakitani K et al. Regulation of energy metabolism by interleukin-1β, but not by interleukin-6, is mediated by nitric oxide in primary cultured rat hepatocytes. Biochem. Biophys. Acta 1996; 1311: 20-6.
17. 17. Satoi S, Kamiyama Y, Kitade H et al. Prolonged decreases in plasma nitrate levels at early postoperative phase after hepato-pancreatobiliary surgery, J. Lab. Clin. Med. 1998; 131: 236-42.
18. 18. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992; 20: 864-74.
19. 19. Uno S, Itoh M, Kurono Y et al. A simple and sensitive assay for blood ketone bodies using highly purified β-hydroxybutyrate dehydrogenase. Clin. Chim. Acta 1987; 168: 253-5.
20. 20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE: A severity of disease classification system. Crit. Care Med. 1985; 13: 818-29.
21. 21. Ochoa JB, Udekwu AO, Billiar TR et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 1991; 214: 621-6.
22. 22. Henry Y, Lepoivre M, Drapier JC et al. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 1993; 7: 1124-34.
23. 23. Curran RD, Billiar TR, Stuehr DJ et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann. Surg. 1990; 212: 462-71.
24. 24. Nussler AK, Di Silvio M, Billiar TR et al. Stimulation of the nitric oxide symhase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 1992; 176: 261-4.
25. 25. Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit. Care Med. 1995; 23: 835-42.
26. 26. Hibbs JB, Westenfelder C, Taintor R et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 1992; 89: 867-77.
27. 27. Ioannidis I, Hellinger A, Dehmlow C et al. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 1995; 59: 1293-7.
28. 28. Doughty L, Carcillo JA, Kaplan S, Janosky J. Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis. Crit. Care Med. 1998; 26: 157-62.
29. 29. Tanaka J, Ozawa K, Tobe T. Significance of blood ketone body ratio as an indicator of hepatic cellular energy status in jaundiced rabbits. Gastroenterotogy 1979; 76: 691-6.
30. 30. Saibara T, Maeda T, Onishi S, Yamamoto Y. Plasma exchange and the arterial blood ketone body ratio in patients with acute hepatic failure. J. Hepatol. 1994; 20: 617-22.
31. 31. Kiuchi T, Ozawa K, Yamamoto Y et al. Changes in arterial ketone body ratio in the phase immediately after hepatectomy. Prognostic implications. Arch. Surg. 1990; 125: 655-9.
32. 32. Yamaoka Y, Washida M, Manaka D et al. Arterial ketone body ratio as a predictor of donor liver viability in human liver transplantation. Transplantation 1993; 55: 92-5.
33. 33. Uemoto S, Inomata Y, Egawa H et al. Effects of hypoxemia on early postoperative course of liver transplantation in pediatric patients with intrapulmonary shunting. Transplantation 1997; 63: 407-14.
34. 34. Matsushita K, Kawasaki S, Makuuchi M. Arterial ketone body ratio in liver surgery. Hepatology 1994; 20: 331-5.
35. 2 supply dependence. J. Appl. Physiol. 1992; 72: 1499-505.